SEC Form 4 · accession 0001209191-18-046236
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn Coleman
Officer — CVP, CHIEF FINANCIAL OFFICER
Period of report
Aug 9, 2018
Accepted (ET)
Aug 10, 2018 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 9, 2018 | S | 8,916 | $63.0022 | D | 16,795 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $63 to $63.011.